Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_assertion type Assertion NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_head.
- NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_assertion description "[Other narcoleptic markers also frequently found in patients without narcolepsy included ESS>14 (78% of 27 patients), UNS>14 (75%), REM symptoms (30%), sleep latencies on MSLT<5 min (41%), >/=2 SOREM (30%), DQB1*0602 positivity (52%), BMI>25 (52%), and increased CSF leptin (48%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_provenance.
- NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_assertion evidence source_evidence_literature NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_provenance.
- NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_assertion SIO_000772 14592354 NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_provenance.
- NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_assertion wasDerivedFrom befree-20140225 NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_provenance.
- NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_assertion wasGeneratedBy ECO_0000203 NP628930.RAuDv4h61nDu_7K0IaL4S4SdhlHu5w_XPv7WhopOm7cXU130_provenance.